Date/Time: Sunday, October 21, 2018 - 3:30 PM to 5:30 PM
Type: Special Interest Group
Room: Hanover C
Chair: Andrew C. Charles, MD – University of California, Los Angeles Co-Chair: Todd J. Schqedt, MD – Mayo Clinic Migraine is the most common neurological disease, making an up-to-date understanding of migraine mechanisms and treatments relevant for all neurologists and neuroscientists, regardless of their specialty. This SIG will focus on advances in the understanding of migraine mechanisms that have identified new therapeutic targets. Important data on headache disorders presented at the meeting will be highlighted, and new and emerging therapies for migraine and other headache disorders will be the topic of an interactive discussion.
1. Discuss ictal changes in the vasculature during migraine describe the relationship of migraine and arterial function, including endothelial dysfunction, dissection, and atherosclerosis
2. Describe the relationship of the migraine and venous circulation, including venous thrombosi